These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 31724892

  • 21. The stimulative function of long noncoding RNA CDKN2B-AS1 in osteosarcoma by targeting the microRNA-122/CCNG1 axis.
    Abula A, Saimaiti G, Maimaiti X, Wuqikun W, Abulaiti A, Ren P, Yusufu A.
    J Recept Signal Transduct Res; 2022 Feb; 42(1):71-79. PubMed ID: 33283575
    [Abstract] [Full Text] [Related]

  • 22. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q, Mo F, Cai X, Zhang W, Wang J, Yang S, Liu X.
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [Abstract] [Full Text] [Related]

  • 23. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
    Deng B, Pan R, Ou X, Wang T, Wang W, Nie Y, Chen H.
    Biomed Res Int; 2021 Jun; 2021():5271291. PubMed ID: 33816613
    [Abstract] [Full Text] [Related]

  • 24. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
    Yu CL, Xu NW, Jiang W, Zhang H, Ma Y.
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
    [Abstract] [Full Text] [Related]

  • 25. LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504.
    Wu X, Yan L, Liu Y, Shang L.
    Aging (Albany NY); 2020 Dec 19; 13(1):219-227. PubMed ID: 33401251
    [Abstract] [Full Text] [Related]

  • 26. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
    Kun-Peng Z, Chun-Lin Z, Xiao-Long M.
    Int J Biol Sci; 2017 Dec 19; 13(9):1180-1191. PubMed ID: 29104509
    [Abstract] [Full Text] [Related]

  • 27. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2.
    Zhang B, Fan DB, Liu L, Qin Y, Feng DQ.
    Eur Rev Med Pharmacol Sci; 2020 Jun 19; 24(12):6533-6539. PubMed ID: 32633340
    [Abstract] [Full Text] [Related]

  • 28. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin CZ, Qu Q, Wang GH, He CJ, Zhou HH.
    Int J Mol Sci; 2016 Aug 30; 17(9):. PubMed ID: 27589728
    [Abstract] [Full Text] [Related]

  • 29. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
    Zhuang H, Cao G, Kou C, Li D.
    J BUON; 2019 Aug 30; 24(4):1441-1448. PubMed ID: 31646789
    [Abstract] [Full Text] [Related]

  • 30. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
    Gu W, Zhang E, Song L, Tu L, Wang Z, Tian F, Aikenmu K, Chu G, Zhao J.
    Biomed Pharmacother; 2018 Oct 30; 106():890-895. PubMed ID: 30119259
    [Abstract] [Full Text] [Related]

  • 31. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
    Lou P, Ding T, Zhan X.
    Cancer Biother Radiopharm; 2021 May 30; 36(4):371-381. PubMed ID: 32706998
    [Abstract] [Full Text] [Related]

  • 32. Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1.
    Li S, Liu F, Pei Y, Wang W, Zheng K, Zhang X.
    Aging (Albany NY); 2019 Sep 16; 11(18):7678-7693. PubMed ID: 31525734
    [Abstract] [Full Text] [Related]

  • 33. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
    He JW, Li DJ, Zhou JH, Zhu YL, Yu BQ.
    Biochem Biophys Res Commun; 2020 Jun 04; 526(3):670-677. PubMed ID: 32248969
    [Abstract] [Full Text] [Related]

  • 34. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
    Rankin CR, Lokhandwala ZA, Huang R, Pekow J, Pothoulakis C, Padua D.
    Life Sci; 2019 Aug 15; 231():116571. PubMed ID: 31207308
    [Abstract] [Full Text] [Related]

  • 35. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C, Zhai J, Fu Y.
    Neoplasma; 2020 Jul 15; 67(4):782-793. PubMed ID: 32305052
    [Abstract] [Full Text] [Related]

  • 36. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
    Liu Y, Wang D, Ji Q, Yan J.
    Mol Biotechnol; 2022 Jan 15; 64(1):66-74. PubMed ID: 34542816
    [Abstract] [Full Text] [Related]

  • 37. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S, Li W, Guo A.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30944201
    [Abstract] [Full Text] [Related]

  • 38. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y, Zhang J, Liang S, Lang G, Liu G, Liu P, Deng X.
    J BUON; 2019 Apr 30; 24(5):2090-2098. PubMed ID: 31786880
    [Abstract] [Full Text] [Related]

  • 39. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
    Yang G, Song R, Wang L, Wu X.
    Biomed Pharmacother; 2018 Jul 30; 103():1238-1245. PubMed ID: 29864904
    [Abstract] [Full Text] [Related]

  • 40. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
    Tang J, Huang F, Wang H, Cheng F, Pi Y, Zhao J, Li Z.
    Bosn J Basic Med Sci; 2021 Feb 01; 21(1):39-46. PubMed ID: 32156253
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.